Expertise in
1
conditions

Dr. Thomas Amankonah

Internal Medicine
University Pathology Associates PLLC
2500 N State St, 
Jackson, MS 
Expertise in
1
conditions
University Pathology Associates PLLC
2500 N State St, 
Jackson, MS 

Overview

Thomas Amankonah is an Internal Medicine provider in Jackson, Mississippi. Dr. Amankonah is highly rated in 1 condition, according to our data. His top areas of expertise are Hepatitis, Alcoholic Cirrhosis, Visceromegaly, Hepatitis C, and Endoscopy.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Internal Medicine

Licenses

Internal Medicine in MS

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
PacificSource
  • PPO
Prominence Health
  • EPO
  • PPO

Locations

University Pathology Associates PLLC
2500 N State St, Jackson, MS 39216

Additional Areas of Focus

Dr. Amankonah has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The HepQuant SHUNT Liver Diagnostic Kit for Likelihood of Large Esophageal Varices: The SHUNT-V Study
The HepQuant SHUNT Liver Diagnostic Kit for Likelihood of Large Esophageal Varices: The SHUNT-V Study
Enrollment Status: Completed
Publish Date: April 11, 2025
Intervention Type: Combination product
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Rifaximin 550 Mg In Subjects With Severe Hepatic Impairment And Overt Hepatic Encephalopathy
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Rifaximin 550 Mg In Subjects With Severe Hepatic Impairment And Overt Hepatic Encephalopathy
Enrollment Status: Terminated
Publish Date: January 09, 2024
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
View 3 Less Clinical Trials

1 Total Publications

Diffuse hepatic epithelioid hemangioendothelioma developed in a patient with hepatitis C cirrhosis.
Diffuse hepatic epithelioid hemangioendothelioma developed in a patient with hepatitis C cirrhosis.
Journal: Case reports in transplantation
Published: July 15, 2014
Similar Doctors
Expertise in
7
conditions
Dr. Yoshitsugu Obi
Internal Medicine
Expertise in
7
conditions
Dr. Yoshitsugu Obi
Internal Medicine

University Pathology Associates PLLC

2500 N State St, 
Jackson, MS 
 (0.1 miles away)
601-984-5670
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Yoshitsugu Obi is an Internal Medicine provider in Jackson, Mississippi. Dr. Obi is highly rated in 7 conditions, according to our data. His top areas of expertise are Chronic Kidney Disease, High Potassium Level, End-Stage Renal Disease (ESRD), Hypercalcemia, and Kidney Transplant.

Expertise in
46
conditions
Dr. Natale Sheehan
Internal Medicine
Expertise in
46
conditions
Dr. Natale Sheehan
Internal Medicine

Jackson Oncology Associates

1227 N State St Ste 101, 
Jackson, MS 
 (1.3 miles away)
601-355-2485
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Natale Sheehan is an Internal Medicine provider in Jackson, Mississippi. Dr. Sheehan is highly rated in 46 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, RUNX1 Familial Platelet Disorder, Breast Cancer, and Familial Pancreatic Cancer.

Expertise in
43
conditions
Dr. Bobby Graham
Internal Medicine
Expertise in
43
conditions
Dr. Bobby Graham
Internal Medicine

St. Dominic-Jackson Memorial Hospital

969 Lakeland Dr, 
Jackson, MS 
 (0.3 miles away)
601-200-5900
Languages Spoken:
English
See accepted insurances

Bobby Graham is an Internal Medicine provider in Jackson, Mississippi. Dr. Graham is highly rated in 43 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Gastrostomy.

Frequently Asked Questions about Dr. Thomas Amankonah

How do I make an appointment with Dr. Thomas Amankonah?

You can book an appointment with Dr. Thomas Amankonah by calling their office at 601-984-4540. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Thomas Amankonah a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thomas Amankonah is classified as an Advanced expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Thomas Amankonah specialize in?

While Dr. Thomas Amankonah is a Internal Medicine, they have specific expertise in Hepatitis, Alcoholic Cirrhosis, and Visceromegaly. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Thomas Amankonah participate in research or clinical trials?

Yes. Dr. Thomas Amankonah has published 1 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Thomas Amankonah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Thomas Amankonah accept my insurance?

Dr. Thomas Amankonah accepts most major insurance plans, including Humana and PacificSource. We recommend calling the office directly at 601-984-4540 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Amankonah's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile